Document Detail

[Utilization of Essure® micro-insert for hydrosalpynx occlusion in infertile women].
MedLine Citation:
PMID:  22226634     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To assess the feasibility and the results on fertility of tubal hysteroscopic proximal occlusion with Essure(®) micro-insert in women with hydrosalpinges.
PATIENTS AND METHODS: Thirteen infertile women with hydrosalpinges, who underwent hysteroscopic tubal exclusion by Essure(®) prior to IVF procedure.
RESULTS: The placement of micro-insert was feasible and easy in every patient, with no intra-operative complication. Only one postoperative infectious complication (pyosalpinx) occurred. We report a 64 % rate of pregnancy, and a 18 % rate of normally ongoing pregnancies with no Essure(®)-related complication.
CONCLUSION: Hydrosalpinges occlusion by Essure(®) device might be an easy and safe alternative to laparoscopic treatment, with successful results on fertility and without adverse effects on pregnancy outcomes.
N Thébault; P-L Broux; L Moy; J Vialard
Publication Detail:
Type:  English Abstract; Journal Article     Date:  2012-01-05
Journal Detail:
Title:  Journal de gynécologie, obstétrique et biologie de la reproduction     Volume:  41     ISSN:  1773-0430     ISO Abbreviation:  J Gynecol Obstet Biol Reprod (Paris)     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-03     Completed Date:  2012-08-06     Revised Date:  2014-08-12    
Medline Journal Info:
Nlm Unique ID:  0322206     Medline TA:  J Gynecol Obstet Biol Reprod (Paris)     Country:  France    
Other Details:
Languages:  fre     Pagination:  145-50     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Masson SAS. All rights reserved.
Vernacular Title:
Utilisation du micro-implant Essure® pour exclusion d'hydrosalpinx dans un contexte d'infertilité.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Fallopian Tube Diseases / complications*,  surgery*
Fertilization in Vitro / methods*
Infertility, Female / etiology*,  therapy
Sterilization, Tubal / instrumentation,  methods

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  TAK1 negatively regulates NF-?B and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils.
Next Document:  Structural and biochemical insight into glycogenin inactivation by the glycogenosis-causing T82M mut...